These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 36189307)

  • 21. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel aging-associated lncRNA signature for predicting prognosis in osteosarcoma.
    He Y; Huang X; Ma Y; Yang G; Cui Y; Lv X; Zhao R; Jin H; Tong Y; Zhang X; Li J; Peng M
    Sci Rep; 2024 Jan; 14(1):1386. PubMed ID: 38228673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes.
    Tang H; Liu S; Luo X; Sun Y; Li X; Luo K; Liao S; Li F; Liang J; Zhan X; Wei Q; Liu Y; He M
    Front Immunol; 2023; 14():1150588. PubMed ID: 37090691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes.
    Feng L; Chen Y; Mei X; Wang L; Zhao W; Yao J
    Cancer Biother Radiopharm; 2024 Sep; 39(7):517-531. PubMed ID: 38512709
    [No Abstract]   [Full Text] [Related]  

  • 25. A glycometabolic gene signature associating with immune infiltration and chemosensitivity and predicting the prognosis of patients with osteosarcoma.
    Wang F; Yang K; Pan R; Xiang Y; Xiong Z; Li P; Li K; Sun H
    Front Med (Lausanne); 2023; 10():1115759. PubMed ID: 37293295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
    Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
    Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
    Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients.
    Yan L; Li R; Li D; Zhu Y; Lv Z; Wang B
    Clin Transl Oncol; 2023 Dec; 25(12):3501-3518. PubMed ID: 37219824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
    Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
    Front Immunol; 2022; 13():992266. PubMed ID: 36405691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of prognostic values of immune infiltration and LGMN expression in the microenvironment of osteosarcoma.
    Xu H; Xu D; Zheng Y; Wang H; Li A; Zheng X
    Discov Oncol; 2024 Jul; 15(1):275. PubMed ID: 38980440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and validation of an oxidative-stress-related risk model for predicting the prognosis of osteosarcoma.
    Wang H; Li J; Li X
    Aging (Albany NY); 2023 Jun; 15(11):4820-4843. PubMed ID: 37285835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
    Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
    BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Activated Dendritic-Cell-Related Gene Signature Indicative of Disease Prognosis and Chemotherapy and Immunotherapy Response in Colon Cancer Patients.
    Ouyang Y; Yu M; Liu T; Suo M; Qiao J; Wang L; Li N
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a pro-protein synthesis osteosarcoma subtype for predicting prognosis and treatment.
    Yi C; Liu J; Zhao S; Gong D; Xu B; Li A; Bian E; Tian D
    Sci Rep; 2024 Jul; 14(1):16475. PubMed ID: 39014082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive investigation of tumor immune microenvironment and prognostic biomarkers in osteosarcoma through integrated bulk and single-cell transcriptomic analysis.
    Shi S; Zhang L; Guo X
    Front Immunol; 2024; 15():1424950. PubMed ID: 39108264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Novel Defined Necroptosis-Related Genes Prognostic Signature for Predicting Prognosis and Treatment of Osteosarcoma.
    Zhao S; Wang T; Huang F; Zhao Q; Gong D; Liu J; Yi C; Liang S; Bian E; Tian D; Jing J
    Biochem Genet; 2024 Apr; 62(2):831-852. PubMed ID: 37460861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EMT-related gene classifications predict the prognosis, immune infiltration, and therapeutic response of osteosarcoma.
    Li MP; Long SP; Liu WC; Long K; Gao XH
    Front Pharmacol; 2024; 15():1419040. PubMed ID: 39170698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a pyroptosis-related prognostic signature associated with osteosarcoma metastasis and immune infiltration.
    Gong Z; Wan Y; Han E; Zhou X; Huang J; Yu H; Shi Y; Lian K
    Medicine (Baltimore); 2024 Apr; 103(14):e37642. PubMed ID: 38579086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
    Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
    Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma.
    Yang S; Liu L; Liu X; Li X; Zheng Y; Ren Z; Wang R; Wang Y; Li Q
    Medicine (Baltimore); 2023 Nov; 102(46):e36046. PubMed ID: 37986397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.